Thermo Fisher Scientific Inc (NYSE:TMO) under-valued by 10%
| Website | https://www.thermofisher.com/ |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Fiscal Year End | Dec 31, 2021 |
| Market Cap | $179,594,149,888 |
| Beta | 0.768891 |
| Average Volume | $1,751,309 |
| Last Dividend | 0.92% |
| Price on Aug 5, 2022 | $508.66 |
| Autochartist™ Valuation | $561.41 |
| Conclusion |
10% under-valued |
| Download Report |
